| JVMIX | VVONX | JVMIX / VVONX | |
| Total Expense Ratio | 0.85 | 0.74 | 115% |
| Annual Report Gross Expense Ratio | 0.86 | 0.74 | 116% |
| Fund Existence | 28 years | 15 years | - |
| Gain YTD | 7.607 | 10.938 | 70% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250000 | 1000000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 23.4B | 5.71B | 410% |
| Annual Yield % from dividends | 0.75 | 0.55 | 137% |
| Returns for 1 year | -7.00 | 2.75 | -254% |
| Returns for 3 years | 12.51 | 41.03 | 30% |
| Returns for 5 years | 31.58 | 95.35 | 33% |
| Returns for 10 years | 44.83 | 80.89 | 55% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ETCGX | 50.64 | N/A | N/A |
| Eventide Gilead C | |||
| DFMLX | 36.41 | -0.07 | -0.19% |
| DF Dent Midcap Growth Institutional Plus | |||
| IGFSX | 10.63 | -0.04 | -0.37% |
| VY® Morgan Stanley Global Franchise S2 | |||
| MGIAX | 44.60 | -0.49 | -1.09% |
| MFS International Intrinsic Value A | |||
| GMOIX | 32.42 | -0.46 | -1.40% |
| GMO International Equity III | |||